Journavx, a new non-opioid pain medication, offers a safer alternative for managing acute pain while reducing the risk of ...

Experts discuss the current research on the use of digital therapeutics for managing chronic pain in rheumatic disease.

A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.

New research from McGill University reveals that listening to music at your own rhythm can significantly reduce pain.

Scientists reveal how CBD could help ease chronic pain, anxiety, and mood disorders. Researchers have uncovered a potential ...

On Wednesday, the U.S. Food and Drug Administration approved a new pain management drug which could change the way healthcare ...

While New Orleans prepares for the excitement of the big game, it’s important to remember that sports injuries aren’t limited to the professionals. High school athletes, weekend warriors, and generall ...

12 Simple Decor Choices That Instantly Make Your Home Look More Expensive Near-Earth asteroid Bennu could hit Earth in 157 ...

Dr. Sanjay Gupta said Tuesday that the approval of a new non-opioid pain medication is “a pretty big deal.” “This is a pretty ...

Librela (bedinvetmab injection) is a monthly injectable monoclonal antibody, for which real-world drug experience data has ...

Suzetrigine, to be sold under the brand name Journavx, is the first new type of pain medicine approved by the FDA in more ...

The U.S. Food and Drug Administration has approved a novel prescription pain medication that targets sodium channels involved ...